Aortic Valve Disease, Transcatheter Aortic Valve Replacement, and the Heart Failure Patient

JACC Heart FailPublication date not resolved

Study context

Population: Patients with heart failure (HF) and concomitant aortic stenosis (AS)

As reported in the abstract

Role of TAVR and AS phenotypes in HF (narrative review)

Concomitant AS in HF associated with high rates of mortality and morbidity
Increasing data in favor of transcatheter aortic valve replacement (TAVR) in diverse clinical scenarios, particularly asymptomatic AS and moderate AS
Limited information on advantages of HF medical therapy before and after intervention

Aortic Valve Disease, Transcatheter Aortic Valve Replacement, and the Heart Failure Patient. JACC Heart Fail. doi:10.1016/j.jchf.2023.07.003

Summarised from the published abstract; every number is checked against it